$IXHL Cashflow Statement | Understand Stock

$IXHL

$2.58 -$0.13 (4.8%) Close

$IXHL Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2026 12 months to Jun 30, 2026	FY2025 12 months to Jun 30, 2025	FY2024 12 months to Jun 30, 2024	FY2023 12 months to Jun 30, 2023	FY2022 12 months to Jun 30, 2022
Receipts from other income
Payments to suppliers and employees
Interest received and other income
Net cash (used in) operating activities
Payments for the addition of property, plant and equipment
Net cash from investing activities
Proceeds from shares issued (net of costs)
Repayment of lease liabilities
Net cash from financing activities
Net increase in cash and cash equivalents
Net decrease in cash and cash equivalents
Cash and cash equivalents at beginning of the year
Effect of exchange rate fluctuations on cash held
Cash and cash equivalents at end of the year
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Unrealized loss on foreign currency remeasurement
Non-cash expense of ELOC commitment
Stock-based compensation expense
Change in fair value of warrant liabilities
ELOC Warrant
Total change in fair value of warrant liabilities
Change in fair value of convertible rights
Non-cash interest expense
Loss on extinguishment
Share of earnings (loss) of joint venture
Change in operating assets and liabilities:
Prepaid expenses and other current assets
Acquisition of in-process research and development
R&D tax incentive receivable
Trade and other payables

Net cash used in operating activities
Cash flows from investing activities:
Purchase of property, plant and equipment
Investment of joint venture
Net cash used in investing activities
Cash flows from financing activities:
Proceeds received from facility agreement
Repayment of facility agreement
Proceeds from share issuance
Share issuance costs
Warrant issuance costs
Proceeds from issuance of convertible debt
Cancellation of warrants
Repayment of convertible debt
Debt issuance costs
Share repurchase
Net cash provided by financing activities
Effect of exchange rate changes on cash and cash equivalents
Net increase in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Non-cash investing and financing activities
Issuance of ELOC warrants at initial fair value
Issuance of convertible note warrants at initial fair value
Warrants issued at initial fair value
ELOC Warrant
Convertible Note Warrants
Series A Warrant
Common Stock Warrants
Pre-Funded Warrants
Issuance of convertible rights at initial fair value
Issuance of Series A warrants at initial fair value
Partial conversion of convertible note
Total

Comments